Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a significant global issue that has major implications for the healthcare system. The mortality rates associated with SARS-CoV-2 infection vary according to the geographical region and are associated with age, comorbidities...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgakopoulou, Vasiliki Epameinondas, Basoulis, Dimitrios, Voutsinas, Pantazis M., Makrodimitri, Sotiria, Samara, Stamatia, Triantafyllou, Maria, Eliadi, Irene, Karamanakos, Georgios, Papageorgiou, Chrysovalantis V., Anastasopoulou, Amalia, Bitsani, Aikaterini, Kampouropoulou, Olga, Eleftheriadou, Ioanna, Gkoufa, Aikaterini, Spandidos, Demetrios A., Papalexis, Petros, Sipsas, Nikolaos V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627569/
https://www.ncbi.nlm.nih.gov/pubmed/36340609
http://dx.doi.org/10.3892/etm.2022.11660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627569/
https://www.ncbi.nlm.nih.gov/pubmed/36340609
http://dx.doi.org/10.3892/etm.2022.11660

Ejemplares similares